{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,24]],"date-time":"2023-10-24T00:18:46Z","timestamp":1698106726016},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1989,3,1]],"date-time":"1989-03-01T00:00:00Z","timestamp":604713600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[1989,3]]},"DOI":"10.1007\/bf01665958","type":"journal-article","created":{"date-parts":[[2005,5,9]],"date-time":"2005-05-09T00:51:51Z","timestamp":1115599911000},"page":"86-91","source":"Crossref","is-referenced-by-count":8,"title":["Leukoregulin up-regulation of tumor cell sensitivity to natural killer and lymphokine-activated killer cell cytotoxicity"],"prefix":"10.1007","volume":"30","author":[{"given":"Paulette M.","family":"Furbert-Harris","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles H.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","first-page":"392","volume":"37","author":"TM Anderson","year":"1986","unstructured":"Anderson TM, Ibayashi Y, Holmes EC, Golub SH (1986) Enhancement of NK activity in tumor infiltrating lymphocytes by recombinant interleukin-2. Surg Forum 37: 392","journal-title":"Surg Forum"},{"key":"CR2","first-page":"1180","volume":"48","author":"TM Anderson","year":"1988","unstructured":"Anderson TM, Ibayashi Y, Tokuda Y, Colquhoun SD, Holmes EC, Golub SH (1988) Effects of systemic recombinant interleukin-2 on natural killer and lymphokine activated killer activity of human tumor infiltrating lymphocytes. Cancer Res 48: 1180","journal-title":"Cancer Res"},{"key":"CR3","first-page":"605","volume":"28","author":"N Auersperg","year":"1962","unstructured":"Auersperg N, Hawryluk A (1962) Chromosome observations on three epithelial cell cultures derived from carcinomas of the human cervix. J Natl Cancer Inst 28: 605","journal-title":"J Natl Cancer Inst"},{"key":"CR4","first-page":"2686","volume":"46","author":"SC Barnett","year":"1986","unstructured":"Barnett SC, Evans CH (1986) Leukoregulin-increased plasma membrane permeability and associated ionic fluxes. Cancer Res 46: 2686","journal-title":"Cancer Res"},{"key":"CR5","first-page":"505","volume":"73","author":"SC Barnett","year":"1988","unstructured":"Barnett SC, Evans CH (1988) Leukoregulin-induced translocation of protein kinase C activity in K562 cells. Clin Exp Immunol 73: 505","journal-title":"Clin Exp Immunol"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0008-8749(87)90298-X","volume":"109","author":"ET Bloom","year":"1987","unstructured":"Bloom ET, Babbitt JT (1987) Role of cytokines in the monocyte-mediated augmentation of human natural killer cell activity. Cell Immunol 109: 123","journal-title":"Cell Immunol"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"172","DOI":"10.4049\/jimmunol.137.1.172","volume":"137","author":"ET Bloom","year":"1986","unstructured":"Bloom ET, Babbitt JT, Kawakami K (1986) Monocyte-mediated augmentation of human natural killer cell activity: conditions, monocyte and effector cell characteristics. J Immunol 137: 172","journal-title":"J Immunol"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/0008-8749(86)90255-8","volume":"99","author":"E Braakman","year":"1986","unstructured":"Braakman E, VanTunen A, Meager A, Lucas CJ (1986) IL-2 and IFN\u03b3 enhanced natural cytotoxic activity: analysis of the role of different lymphoid subsets and implications for activation routes. Cell Immunol 99: 476","journal-title":"Cell Immunol"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"276","DOI":"10.4049\/jimmunol.126.1.276","volume":"126","author":"K DeBoer","year":"1981","unstructured":"DeBoer K, Kleinman R, Teodorescu M (1981) Identification and separation by bacterial asherence of human lymphocytes that suppress natural cytotoxicity. J Immunol 126: 276","journal-title":"J Immunol"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0022-1759(84)90081-4","volume":"67","author":"CH Evans","year":"1984","unstructured":"Evans CH (1984) Normal levels of lymphotoxin secretion by freshly isolated and refrigerated human peripheral blood lymphocytes. J Immunol Methods 67: 13","journal-title":"J Immunol Methods"},{"key":"CR11","first-page":"277","volume":"6","author":"CH Evans","year":"1987","unstructured":"Evans CH, Heinbaugh JA, Ransom JH (1987) Flow cytometric evaluation of leukoregulin as an intrinsic molecular mediator of natural killer lymphocyte cytotoxicity. Lymphokine Res 6: 277","journal-title":"Lymphokine Res"},{"key":"CR12","first-page":"283","volume":"5","author":"GM Gersuk","year":"1986","unstructured":"Gersuk GM, Holloway JM, Chang W, Pattengale PK (1986) Inhibition of human natural killer cell activity by plateletderived growth factor. Nat Immun Cell Growth Regul 5: 283","journal-title":"Nat Immun Cell Growth Regul"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1084\/jem.155.6.1823","volume":"155","author":"EA Grimm","year":"1982","unstructured":"Grimm EA, Mazumder A, Zhang HZ, Rosenberg SA (1982) Lymphokine-activated killer cell phenomenon: lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes. J Exp Med 155: 1823","journal-title":"J Exp Med"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1084\/jem.157.3.884","volume":"157","author":"EA Grimm","year":"1983","unstructured":"Grimm EA, Ramsey KM, Mazumder A, Wilson DJ, Djeu JY, Rosenberg SA (1983) Lymphokine-activated killer cell phenomenon II. precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymusderived lymphocytes, and natural killer cells. J Exp Med 157: 884","journal-title":"J Exp Med"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0008-8749(87)90116-X","volume":"110","author":"M Heiskala","year":"1987","unstructured":"Heiskala M, Timonen T (1987) Effect of interleukin-2 on the inhibition of human natural killer activity by monolayer cells. Cell Immunol 110: 209","journal-title":"Cell Immunol"},{"key":"CR16","first-page":"1","volume":"6","author":"M Heiskala","year":"1987","unstructured":"Heiskala M, Ylikorkala O, Timonen T (1987) Inhibition of human natural killer activity by monolayers of primary cell cultures. Nat Immun Cell Growth Regul 6: 1","journal-title":"Nat Immun Cell Growth Regul"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1126\/science.7025208","volume":"214","author":"RB Herberman","year":"1981","unstructured":"Herberman RB and Ortaldo JR (1981) Natural killer cells: their role in defense against disease. Science 214: 24","journal-title":"Science"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.4049\/jimmunol.135.4.2882","volume":"135","author":"J Herman","year":"1985","unstructured":"Herman J, Dinarello CA, Kew MC, Rabson AR (1985) The role of interleukin 1 (IL1) in tumor-NK cell interactions: correction of defective NK cell activity in cancer patients by treating target cells with IL1. J Immunol 135: 2882","journal-title":"J Immunol"},{"key":"CR19","first-page":"2834","volume":"46","author":"M Hoyer","year":"1986","unstructured":"Hoyer M, Meineke T, Lewis W, Zwilling B, Rinehart H (1986) Characterization and modulation of human lymphokine (interleukin-2) activated killer cell induction. Cancer Res 46: 2834","journal-title":"Cancer Res"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"3124","DOI":"10.4049\/jimmunol.134.5.3124","volume":"135","author":"K Itoh","year":"1985","unstructured":"Itoh K, Shiiba K, Shimizu Y, Suzuki R, Kumagai K (1985) Generation of activated killer cells by recombinant interleukin-2 (rIL2) in collaboration with interferon \u03b3 (IFN-\u03b3). J Immunol 135: 3124","journal-title":"J Immunol"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/BF00915159","volume":"8","author":"MC Kanar","year":"1988","unstructured":"Kanar MC, Thiele DL, Ostensen M, Lipsky PE (1988) Regulation of human natural killer (NK) cell function: action of killing of an NK-resistant renal cell carcinoma cell line. J Clin Immunol 8: 69","journal-title":"J Clin Immunol"},{"key":"CR22","first-page":"1300","volume":"28","author":"E Klein","year":"1968","unstructured":"Klein E, Klein G, Nadkarni JS, Nadkarni JJ, Wigzell H, Clifford P (1968) Surface IgM kappa specificity on a Burkitt lymphoma cell in vivo and in derived culture lines. Cancer Res 28: 1300","journal-title":"Cancer Res"},{"key":"CR23","first-page":"1760","volume":"27","author":"AP Kyritsis","year":"1986","unstructured":"Kyritsis AP, Tsokos M, Triche TJ, Chader GJ (1986) Retinoblastoma: a primitive tumor with multipotential characteristics. Invest Ophthalmol Vis Sci 27: 1760","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1182\/blood.V45.3.321.321","volume":"45","author":"CB Lozzio","year":"1975","unstructured":"Lozzio CB, Lozzio BB (1975) Human chronic myelogenous leukemia cell line with positive Philadelphia chromosome. Blood 45: 321","journal-title":"Blood"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1084\/jem.166.3.792","volume":"166","author":"JJ Mule","year":"1987","unstructured":"Mule JJ, Smith CA, Rosenberg SA (1987) Interleukin 4 (B cell stimulatory factor 1) can mediate the induction of lymphokine-activated killer cell activity directed against fresh tumor cells. J Exp Med 166: 792","journal-title":"J Exp Med"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/ijc.2910410108","volume":"41","author":"A Nii","year":"1988","unstructured":"Nii A, Sone S, Utsugi T, Uanagawa H, Ogura T (1988) Up-and down-regulation of human lymphokine (IL-2)-activated killer cell induction by monocytes, depending on their functional state. Int J Cancer 41: 33","journal-title":"Int J Cancer"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"4185","DOI":"10.4049\/jimmunol.138.12.4185","volume":"138","author":"ME Ostensen","year":"1987","unstructured":"Ostensen ME, Thiele DZ, Lipsky PE (1987) Tumor necrosis factor alpha enhances cytolytic activity of human natural killer cells. J Immunol 138: 4185","journal-title":"J Immunol"},{"key":"CR28","first-page":"788","volume":"48","author":"LB Owen-Schaub","year":"1988","unstructured":"Owen-Schaub LB, Gutterman JU, Grimm EA (1988) Synergy of tumor necrosis factor and interleukin 2 in the activation of human cytotoxic lymphocytes: effect of tumor necrosis factor \u03b1 and interleukin 2 in the generation of human lymphokineactivated killer cell cytotoxicity. Cancer Res 48: 788","journal-title":"Cancer Res"},{"key":"CR29","first-page":"152","volume-title":"Natural immunity, cancer and biological response modification","author":"SB Pollack","year":"1986","unstructured":"Pollack SB (1986) Stimulatory effects of OK-432 on natural killer production and activity. In: Lotzova E, Herberman RB (eds) Natural immunity, cancer and biological response modification. Karger, Basel p 152"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/ijc.2910290415","volume":"29","author":"JH Ransom","year":"1982","unstructured":"Ransom JH, Evans CH (1982) Lymphotoxin enhances the susceptibility of neoplastic and preneoplastic cells to natural killer cell-mediated destruction. Int J Cancer 29: 451","journal-title":"Int J Cancer"},{"key":"CR31","first-page":"851","volume":"45","author":"JH Ransom","year":"1985","unstructured":"Ransom JH, Evans CH, McCabe RP, Pomato N, Heinbaugh JA, Chin M, Hanna Jr. MG (1985) Leukoregulin, a direct-acting anticancer immunological hormone that is distinct from lymphotoxin and interferon. Cancer Res 45: 851","journal-title":"Cancer Res"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"526","DOI":"10.4049\/jimmunol.121.2.526","volume":"121","author":"D Santoli","year":"1978","unstructured":"Santoli D, Trinchieri G, Lief FS (1978) Cell-mediated cytotoxicity against virus-infected target cells in humans. 1: characterization of the effector lymphocytes. J Immunol 121: 526","journal-title":"J Immunol"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1099\/0022-1317-68-2-583","volume":"68","author":"H Shirasawa","year":"1987","unstructured":"Shirasawa H, Tomita Y, Sekiya S, Takamizawa H, Simizu B (1987) Integration and transcription of human papillomavirus type 16 and 18 sequences in cell lines derived from cervical carcinomas. J Gen Virol 68: 583","journal-title":"J Gen Virol"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1084\/jem.147.5.1314","volume":"147","author":"G Trinchieri","year":"1978","unstructured":"Trinchieri G, Santoli D (1978) Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells: enhancement of human natural killer cell activity by interferon and antagonistic inhibition of susceptibility of target cells to lysis. J Exp Med 147: 1314","journal-title":"J Exp Med"},{"key":"CR35","first-page":"489","volume":"50","author":"G Trinchieri","year":"1984","unstructured":"Trinchieri G, Perussia B (1984) Human natural killer cells: biologic and pathologic aspects. Lab Invest 50: 489","journal-title":"Lab Invest"},{"key":"CR36","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1093\/jnci\/75.5.849","volume":"75","author":"A Uchida","year":"1985","unstructured":"Uchida A, Vanky F, Klein E (1985) Natural cytotoxicity of human blood lymphocytes and monocytes and their cytotoxic factors: effect of interferon on target cell susceptibility. J Natl Cancer Inst 75: 849","journal-title":"J Natl Cancer Inst"},{"key":"CR37","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.4049\/jimmunol.130.6.2965","volume":"130","author":"SC Wright","year":"1983","unstructured":"Wright SC, Bonavida B (1983) Studies on the mechanism of natural killer cell-mediated cytotoxicity. iv. Interferon-induced inhibition of NK target cell susceptibility to lysis is due to a defect in their ability to stimulate release of natural killer cytotoxic factors (NKCF). J Immunol 130: 2965","journal-title":"J Immunol"},{"key":"CR38","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/BF00205651","volume":"23","author":"M Yagita","year":"1986","unstructured":"Yagita M, Grimm EA (1986) Inhibition of in vitro LAK generation by OK-432. Cancer Immunol Immunother 23: 207","journal-title":"Cancer Immunol Immunother"}],"container-title":["Cancer Immunology Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01665958.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01665958\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01665958","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T05:40:09Z","timestamp":1683092409000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01665958"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1989,3]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1989,3]]}},"alternative-id":["BF01665958"],"URL":"https:\/\/doi.org\/10.1007\/bf01665958","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[1989,3]]}}}